Contrary to findings of this study, Sun et al [15] measured the serum level and expression of ANXA5 in tumor tissues of 93 patients with CRC and 40 healthy individuals and showed a significant higher level of ANXA5 in the serum of CRC patients compared to control group. This evidence concerns the gene ANXA5 and neoplasm.